06.20.2017
Improve Outcomes
$694,540.00
48 months
PERL CGM Study
Funding to evaluate whether increased glycemic variability, as assessed by Continuous Glucose Monitoring (CGM), is associated with an increased risk of renal disease progression in people with type 1 diabetes and diabetic kidney disease.